Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gurupreet Singh Wander"'
Autor:
Rajendra Kumar Jain, Padmanabha Chakravarthi, Rajan Shetty, Padmakumar Ramchandra, Raghava Sarma Polavarapu, Gurupreet Singh Wander, Bishav Mohan, Darshan Navinchandra Banker, Aniruddha Dharmadhikari, Shyam Sundar Bansal, Neeraj Jain, Dharmesh Solanki, Jagdish Dhakaan, Ved Prakash Sharma, Padhinhare P. Mohanan, Parayaru Kottayal Ashokan, Bagur Venkat Manjunath, Narendra Hiregoudar, Chandrashekar Patil, Narasimha Balakrishnan
Publikováno v:
Indian Heart Journal, Vol 68, Iss 5, Pp 599-603 (2016)
Objectives: The aim of the merit-3 study was to determine the safety and performance of the BioMime Sirolimus-Eluting Coronary Stent System (SES) in all-comer patients with coronary artery disease (CAD) in one-year clinical follow-up period. Methods:
Externí odkaz:
https://doaj.org/article/7ba8765f027a46028ab99262e5bd0c2a
Autor:
Majdi Saada, Ofer Kobo, Floris Kauer, Orazbek Sakhov, Peep Laanmets, Rajpal Abhaichand, Iñigo Lozano, Jim Crowley, Gurupreet Singh Wander, Mamas A. Mamas, Ariel Roguin
Publikováno v:
SSRN Electronic Journal.
Autor:
Majdi Saada, Ofer Kobo, Floris Kauer, Orazbek Sakhov, Peep Laanmets, Rajpal Abhaichand, Iñigo Lozano, Jim Crowley, Gurupreet Singh Wander, Mamas A. Mamas, Ariel Roguin
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions. 1:100442
Autor:
Chandrashekar Patil, Padhinhare P. Mohanan, Narasimha Balakrishnan, Shyam Sundar Bansal, Rajendra Kumar Jain, Rajan Shetty, Bishav Mohan, Bagur Venkat Manjunath, Dharmesh Ramakant Solanki, Parayaru Kottayal Ashokan, Raghava Sarma Polavarapu, Padmakumar Ramchandra, Darshan Banker, Narendra Hiregoudar, Aniruddha Dharmadhikari, Neeraj Jain, Padmanabha Chakravarthi, Gurupreet Singh Wander, Jagdish Dhakaan, Ved Prakash Sharma
Publikováno v:
Indian Heart Journal, Vol 68, Iss 5, Pp 599-603 (2016)
Objectives The aim of the merit-3 study was to determine the safety and performance of the BioMime Sirolimus-Eluting Coronary Stent System (SES) in all-comer patients with coronary artery disease (CAD) in one-year clinical follow-up period. Methods T